Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

2-mm Biopsy Margin May Decrease Patient Morbidity

J Am Acad Dermatol; 2017 Dec; Terushkin, Ng, et al

The complete histopathologic removal of nearly 9 of 10 dysplastic nevi (DN), using a peripheral margin of 2 mm of normal skin and a depth at the dermis and subcutaneous fat junction, has the potential to decrease second procedures at DN biopsy sites, thereby decreasing patient morbidity and saving health care dollars, a recent study found. Researchers conducted a prospective study of a saucerization method using a defined 2-mm margin in patients undergoing biopsy of a pigmented skin lesion. They performed 151 biopsies in 138 patients and found:

  • Overall, 137 of 151 lesions subjected to biopsy (90.7%) were melanocytic: 86 DN (57.0%), 40 nevi without atypia (26.5%), and 11 melanomas (7.3%).
  • Of 78 DN, 68 (87.2%) were removed with clear histopathologic margins (8 DN were excluded because of inadequate processing).
  • There was no clinical evidence of recurrence at any of the biopsy sites that were simply observed (ie, not re-excised) over a median of 16.9 months.

Citation:

Terushkin V, Ng E, Stein JA, et al. A prospective study evaluating the utility of a 2-mm biopsy margin for complete removal of histologically atypical (dysplastic) nevi. J Am Acad Dermatol. 2017;77(6):1096-1099. doi:10.1016/j.jaad.2017.07.016.